{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:08:54Z","timestamp":1791295734784,"version":"4.1.0"},"reference-count":70,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2005,3,8]],"date-time":"2005-03-08T00:00:00Z","timestamp":1110240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2005,4]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The molecular aetiology of polycythaemia vera (PV) remains unknown and the differential diagnosis between PV and secondary erythrocytosis (SE) can be challenging. Gene expression profiling can identify candidates involved in the pathophysiology of PV and generate a molecular signature to aid in diagnosis. We thus performed cDNA microarray analysis on 40 PV and 12 SE patients. Two independent data sets were obtained: using a two\u2010step training\/validation design, a set of 64 genes (class predictors) was determined, which correctly discriminated PV from SE patients. Separately 253 genes were identified to be upregulated and 391 downregulated more than 1\u00b75\u2010fold in PV compared with healthy controls (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b701). Of the genes overexpressed in PV, 27 contained Sp1 sites: we therefore propose that altered activity of Sp1\u2010like transcription factors may contribute to the molecular aetiology of PV. One Sp1 target, the transcription factor NF\u2010E2 [nuclear factor (erythroid\u2010derived 2)], is overexpressed 2\u2010 to 40\u2010fold in PV patients. In PV bone marrow, NF\u2010E2 is overexpressed in megakaryocytes, erythroid and granulocytic precursors. It has been shown that overexpression of NF\u2010E2 leads to the development of erythropoietin\u2010independent erythroid colonies and that ectopic NF\u2010E2 expression can reprogram monocytic cells towards erythroid and megakaryocytic differentiation. Transcription factor concentration may thus control lineage commitment. We therefore propose that elevated concentrations of NF\u2010E2 in PV patients lead to an overproduction of erythroid and, in some patients, megakaryocytic cells\/platelets. In this model, the level of NF\u2010E2 overexpression determines both the severity of erythrocytosis and the concurrent presence or absence of thrombocytosis.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2005.05416.x","type":"journal-article","created":{"date-parts":[[2005,3,21]],"date-time":"2005-03-21T14:25:52Z","timestamp":1111415152000},"page":"138-150","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Gene expression profiling in polycythaemia vera: overexpression of transcription factor NF\u2010E2"],"prefix":"10.1111","volume":"129","author":[{"given":"Philipp S.","family":"Goerttler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Kreutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Donauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Faller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Maiwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"M\u00e4rz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitta","family":"Rumberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Titus","family":"Sparna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Schmitt\u2010Gr\u00e4ff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Wilpert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Timmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Walz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike L.","family":"Pahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,3,21]]},"reference":[{"key":"e_1_2_16_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197610212951702"},{"key":"e_1_2_16_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/35000501"},{"key":"e_1_2_16_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/362722a0"},{"key":"e_1_2_16_5_1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini Y.","year":"1995","journal-title":"Journal of Royal Statistical Society"},{"key":"e_1_2_16_6_1","first-page":"307","article-title":"Polycythemia rubra vera","volume":"22","author":"Bilgrami S.","year":"1995","journal-title":"Seminars in Oncology"},{"key":"e_1_2_16_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1201-365"},{"key":"e_1_2_16_8_1","doi-asserted-by":"publisher","DOI":"10.1159\/000206880"},{"key":"e_1_2_16_9_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.45.28181"},{"key":"e_1_2_16_10_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.5.2901"},{"key":"e_1_2_16_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V6.4.372.372"},{"key":"e_1_2_16_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)61011-8"},{"key":"e_1_2_16_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.thj.6200123"},{"key":"e_1_2_16_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(99)03014-1"},{"key":"e_1_2_16_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1987.tb00012.x"},{"key":"e_1_2_16_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V56.1.70.70"},{"key":"e_1_2_16_17_1","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1182\/blood.V58.5.916.916","article-title":"Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell","volume":"58","author":"Fialkow P.J.","year":"1981","journal-title":"Blood"},{"key":"e_1_2_16_18_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2004.02.007"},{"key":"e_1_2_16_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1990.tb15611.x"},{"key":"e_1_2_16_20_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.48.31844"},{"key":"e_1_2_16_21_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.23.9073"},{"key":"e_1_2_16_22_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1999.1037"},{"key":"e_1_2_16_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V51.2.189.189"},{"key":"e_1_2_16_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.2002.00968.x"},{"key":"e_1_2_16_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/9780470316801"},{"key":"e_1_2_16_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.12.3734"},{"key":"e_1_2_16_27_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.11.1625"},{"key":"e_1_2_16_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0949"},{"key":"e_1_2_16_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-03-0919"},{"key":"e_1_2_16_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-03-0744"},{"key":"e_1_2_16_31_1","volume-title":"Current Protocols in Immunology","author":"Kruisbeck A.M.","year":"1991"},{"key":"e_1_2_16_32_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117927"},{"key":"e_1_2_16_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-4781(99)00064-0"},{"key":"e_1_2_16_34_1","doi-asserted-by":"publisher","DOI":"10.1006\/bmme.1997.2643"},{"key":"e_1_2_16_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1119(99)00211-5"},{"key":"e_1_2_16_36_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M310211200"},{"key":"e_1_2_16_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1119(96)00715-9"},{"key":"e_1_2_16_38_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.10.4.1680"},{"key":"e_1_2_16_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-2977(98)00143-0"},{"key":"e_1_2_16_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199802263380903"},{"key":"e_1_2_16_41_1","first-page":"9","article-title":"Diagnostic criteria and prognosis in polycythemia vera and essential thrombocythemia","volume":"36","author":"Murphy S.","year":"1999","journal-title":"Seminars in Hematology"},{"key":"e_1_2_16_42_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1033.2002.03252.x"},{"key":"e_1_2_16_43_1","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.2000.1862"},{"key":"e_1_2_16_44_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.183.4.1829"},{"key":"e_1_2_16_45_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.34.24297"},{"key":"e_1_2_16_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3536(98)80035-8"},{"key":"e_1_2_16_47_1","first-page":"3940","article-title":"Gene expression profiling in Polycythemia Vera using cDNA microarray technology","volume":"63","author":"Pellagatti A.","year":"2003","journal-title":"Cancer Research"},{"key":"e_1_2_16_48_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.8.3511"},{"key":"e_1_2_16_49_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197406132902419"},{"key":"e_1_2_16_50_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.11.1639"},{"key":"e_1_2_16_51_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20031074"},{"key":"e_1_2_16_52_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199809059262"},{"key":"e_1_2_16_53_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-1841"},{"key":"e_1_2_16_54_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M908695199"},{"key":"e_1_2_16_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(01)00194-7"},{"key":"e_1_2_16_56_1","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2002.33755"},{"key":"e_1_2_16_57_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2004.02.011"},{"key":"e_1_2_16_58_1","first-page":"511a","article-title":"Characterization of the promoter for PRV\u20101, a gene overexpressed in Polycythemia vera","volume":"96","author":"Strunck E.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_16_59_1","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/oxfordjournals.jbchem.a124089","article-title":"Functional characterization of the 5\u2032\u2010regulatory region of the human thrombomodulin gene","volume":"113","author":"Tazawa R.","year":"1993","journal-title":"Journal of Biochemistry"},{"key":"e_1_2_16_60_1","first-page":"3","article-title":"Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia","volume":"36","author":"Tefferi A.","year":"1999","journal-title":"Seminars in Hematology"},{"key":"e_1_2_16_61_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.8.2569"},{"key":"e_1_2_16_62_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1996.0307"},{"key":"e_1_2_16_63_1","doi-asserted-by":"publisher","DOI":"10.1677\/jme.0.0240329"},{"key":"e_1_2_16_64_1","doi-asserted-by":"crossref","first-page":"12002","DOI":"10.1016\/S0021-9258(18)37885-2","article-title":"Structure of the human liver\/bone\/kidney alkaline phosphatase gene","volume":"263","author":"Weiss M.J.","year":"1988","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_16_65_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199609074366"},{"key":"e_1_2_16_66_1","volume-title":"Tumours of the Hemopoietic and Lymphoid Tissues","author":"WHO","year":"2001"},{"key":"e_1_2_16_67_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.42.26702"},{"key":"e_1_2_16_68_1","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2002-3-9-research0048"},{"key":"e_1_2_16_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(02)00032-6"},{"key":"e_1_2_16_70_1","doi-asserted-by":"crossref","first-page":"11425","DOI":"10.1016\/S0021-9258(19)78141-1","article-title":"Sp1 is a critical factor for the monocytic specific expression of human CD14","volume":"269","author":"Zhang D.E.","year":"1994","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_16_71_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M001389200"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2005.05416.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2005.05416.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T16:29:08Z","timestamp":1735316948000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2005.05416.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,21]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["10.1111\/j.1365-2141.2005.05416.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05416.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,21]]},"assertion":[{"value":"2005-03-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}